Skip to content

A comparative study of visual outcomes after implantation of extended-depth-of-focus and enhanced monofocal intraocular lenses

A comparative study of visual outcomes after implantation of extended-depth-of-focus and enhanced monofocal intraocular lenses

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093961
Enrollment
Unknown
Registered
2024-12-13
Start date
2024-12-16
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

vivity group:AcrySof IQ Vivity IOL implantation
ICB00 group:Tecnis Eyhance IOL implantation

Sponsors

Eye Center of Second Affiliated hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Elderly cataract patients aged 40-80 who came to our hospital during the study period; (2) Preoperative corneal astigmatism <=-1.0D, Kappa angle (the angle between the pupillary axis and the visual axis) <=0.7mm; (3) Exclude other active ocular diseases and ocular trauma; (4) Have not undergone other eye surgery within 3 months; (5) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Excluded were patients with allergy to any of the study medications, corneal diseases or ocular infectious disease, history of ocular chemical or thermal burn or any ocular operation, glaucoma or ocular hypertension, history of serious systemic disease, or other conditions that in the opinion of the investigator precluded enrollment. Patients who were initially included were excluded if they had intraoperative or postoperative complications. Women who were pregnant or lactating were not permitted to be in the study.(1) Patients younger than 40 years old or older than 80 years old; (2) Presence of other eye diseases such as severe ocular inflammation, dry eye, infection, high myopia, macular degeneration or poor glaucoma control; (3) History of ocular trauma or other ocular surgery; (4) Have a history of systemic diseases and systemic medication that clearly affect vision; (5) History of strabismus, amblyopia, or abnormal pupils, crystals and suspensory ligaments; (6) Those who participated in other clinical trials or lost to follow-up during the follow-up period.

Design outcomes

Primary

MeasureTime frame
Visual acuity;

Secondary

MeasureTime frame
Intraocular Pressure, IOP;Defocus curve;Tolerance to Induced Astigmatism;

Countries

China

Contacts

Public ContactKe Yao

Eye Center of Second Affiliated hospital of Zhejiang University School of Medicine

xlren@zju.edu.cn+86 139 0651 7262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026